BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, offering promising developments across several health care and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, more dependable substitute for therapeutic use